Search
-
Finance Home
-
Yahoo!
-
Help
Wednesday, June 19 2013 7:33am ET - U.S. Markets open in 1 hour and 57 minutes.
Home
Investing
Market Overview
Market Stats
Stocks
Mutual Funds
ETFs
Bonds
Options
Industries
Currencies
Education
Commodities
News & Opinion
Markets
Investing Ideas
Expert Advice
Special Editions
Company Finances
Providers
Video
Personal Finance
Banking & Budgeting
Career & Work
College & Education
Family & Home
Insurance
Loans
Real Estate
Retirement
Taxes
Lifelong Investing
new!
EXCLUSIVES
Breakout
The Daily Ticker
Daniel Gross
Financially Fit
Get Quotes
Finance Search
96989976
Industry Center - Drug Delivery
Industry Center
>
Drug Delivery
> Upcoming Events
More On This Industry
·
Summary
·
News
·
Leaders & Laggards
·
Company Index
·
Industry Browser
Related Industries
·
Biotechnology
·
Diagnostic Substances
·
Drug Manufacturers - Major
·
Drug Manufacturers - Other
·
Drug Related Products
·
Drugs - Generic
Top Industries
·
Aerospace/Defense - Major Diversified
·
Auto Manufacturers - Major
·
Biotechnology
·
Business Software & Services
·
Chemicals - Major Diversified
·
Communication Equipment
·
Conglomerates
·
Diversified Computer Systems
·
Diversified Investments
·
Drug Manufacturers - Major
·
Electric Utilities
·
Food - Major Diversified
·
Industrial Metals & Minerals
·
Major Airlines
·
Major Integrated Oil & Gas
·
Money Center Banks
·
Property & Casualty Insurance
·
Semiconductor - Broad Line
·
Telecom Services - Domestic
Complete Industry List...
Recent Events for Drug Delivery
View:
Upcoming Events
|
Recent Events
Date
Company
Event
04/18/13
ALKS
Alkermes plc downgraded by Mizuho
04/10/13
PSDV
pSivida Corp. upgraded by Ladenburg Thalmann
03/08/13
HSP
Hospira Inc upgraded by UBS
02/22/13
VRX
Valeant Pharmaceuticals Interna coverage initiated by Aegis Capital
01/31/13
IPCI
Intellipharmaceutics Internatio coverage initiated by Maxim Group
01/23/13
ALKS
Alkermes plc downgraded by MKM Partners
11/16/12
ALKS
Alkermes plc coverage initiated by Mizuho
09/11/12
IPCI
Intellipharmaceutics Internatio coverage initiated by Brean Murray
08/14/12
ELN
Elan Corporation, plc ADR upgraded by UBS
01/25/12
ALKS
Alkermes plc upgraded by MKM Partners
10/27/11
HSP
Hospira Inc downgraded by RBC Capital Mkts
06/24/11
IPCI
Intellipharmaceutics Internatio coverage initiated by Ladenburg Thalmann
06/21/11
ALKS
Alkermes plc coverage initiated by MKM Partners
04/07/11
ELN
Elan Corporation, plc ADR upgraded by RBC Capital Mkts
02/14/11
HSP
Hospira Inc coverage initiated by Collins Stewart
01/18/11
HSP
Hospira Inc coverage initiated by Barclays Capital
01/06/11
ELN
Elan Corporation, plc ADR upgraded by RBC Capital Mkts
10/20/10
ALKS
Alkermes plc downgraded by Caris & Company
10/05/10
CBRX
Columbia Laboratories, Inc. coverage initiated by The Benchmark Company
09/30/10
ALKS
Alkermes plc coverage initiated by UBS
More Recent Events...
Sponsor Results
NFP Advisor Services
An exclusive network of highly successful Investment Advisors
www.nfpasg.com
Retirement Annuity Income
7% Guaranteed Life Time Income. Reduced Risk For Retirees Here.
AdvisorWorld.com/Retirement
2.13% Mortgage Refinance
$160,000 Mortgage for $601/Mo. Secure. No Hidden Fees. 3.0% APR
eLendingSaver.com
(
What's This?
)
Copyright © 2013 Yahoo! Inc. All rights reserved.
Privacy Policy
-
Terms of Service
Industry information © 2013
Morningstar, Inc.
All Rights Reserved. Company information © 2013
Capital IQ
All Rights Reserved. Quotes and other information supplied by independent providers identified on the Yahoo! Finance
partner page
. S&P 500 index provided by
Comstock
. All rights reserved. Top-Ranked Analyst information © 1999-2013,
StarMine Corp.
All rights reserved. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo! nor any of its data or content providers (such as Capital IQ, Morningstar, CSI and exchanges) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Yahoo! site, a user agrees not to redistribute the information found therein.
Questions or Comments?